These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 29155281)
1. Effect of oregano essential oil and carvacrol on Cryptosporidium parvum infectivity in HCT-8 cells. Gaur S; Kuhlenschmidt TB; Kuhlenschmidt MS; Andrade JE Parasitol Int; 2018 Apr; 67(2):170-175. PubMed ID: 29155281 [TBL] [Abstract][Full Text] [Related]
2. Functionalization of Lipid-Based Nutrient Supplement with β-Cyclodextrin Inclusions of Oregano Essential Oil. Gaur S; Lopez EC; Ojha A; Andrade JE J Food Sci; 2018 Jun; 83(6):1748-1756. PubMed ID: 29771453 [TBL] [Abstract][Full Text] [Related]
3. [Highly Active AntiRetroviral Therapy and cryptosporidiosis]. Morales Gomez MA Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695 [TBL] [Abstract][Full Text] [Related]
4. The effect of thermal treatments on the viability and infectivity of Cryptosporidium parvum on beef surfaces. Moriarty EM; Duffy G; McEvoy JM; Caccio S; Sheridan JJ; McDowell D; Blair IS J Appl Microbiol; 2005; 98(3):618-23. PubMed ID: 15715864 [TBL] [Abstract][Full Text] [Related]
5. Improvement of in vitro evaluation of chemical disinfectants for efficacy on Cryptosporidium parvum oocysts. Delling C; Lendner M; Müller U; Daugschies A Vet Parasitol; 2017 Oct; 245():5-13. PubMed ID: 28969838 [TBL] [Abstract][Full Text] [Related]
6. Comparison of viability assays for Cryptosporidium parvum oocysts after disinfection. Joachim A; Eckert E; Petry F; Bialek R; Daugschies A Vet Parasitol; 2003 Jan; 111(1):47-57. PubMed ID: 12523978 [TBL] [Abstract][Full Text] [Related]
7. Die-off of Cryptosporidium parvum in soil and wastewater effluents. Nasser AM; Tweto E; Nitzan Y J Appl Microbiol; 2007 Jan; 102(1):169-76. PubMed ID: 17184332 [TBL] [Abstract][Full Text] [Related]
8. Anti-protozoal activity of extracts from chicory (Cichorium intybus) against Cryptosporidium parvum in cell culture. Woolsey ID; Valente AH; Williams AR; Thamsborg SM; Simonsen HT; Enemark HL Sci Rep; 2019 Dec; 9(1):20414. PubMed ID: 31892721 [TBL] [Abstract][Full Text] [Related]
9. Investigations of the relationship between use of in vitro cell culture-quantitative PCR and a mouse-based bioassay for evaluating critical factors affecting the disinfection performance of pulsed UV light for treating Cryptosporidium parvum oocysts in saline. Garvey M; Farrell H; Cormican M; Rowan N J Microbiol Methods; 2010 Mar; 80(3):267-73. PubMed ID: 20096310 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice. Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052 [TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation. Lee SU; Joung M; Nam T; Park WY; Yu JR Korean J Parasitol; 2009 Mar; 47(1):7-11. PubMed ID: 19290085 [TBL] [Abstract][Full Text] [Related]
12. Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms. Carryn S; Schaefer DA; Imboden M; Homan EJ; Bremel RD; Riggs MW J Parasitol; 2012 Feb; 98(1):199-204. PubMed ID: 21787211 [TBL] [Abstract][Full Text] [Related]
13. Antiviral efficacy and mechanisms of action of oregano essential oil and its primary component carvacrol against murine norovirus. Gilling DH; Kitajima M; Torrey JR; Bright KR J Appl Microbiol; 2014 May; 116(5):1149-63. PubMed ID: 24779581 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Cryptosporidium parvum development in various cell lines for screening in vitro drug testing. Siripanth C; Punpoowong B; Amarapal P; Thima N; Eampokalap B; Kaewkungwal J Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):540-6. PubMed ID: 15689063 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies. Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250 [TBL] [Abstract][Full Text] [Related]
16. Effect of Ginsenoside-Rh2 and Curcurbitacin-B on Cryptosporidium parvum in vitro. Shahiduzzaman M; Ras R; Widmer G Exp Parasitol; 2020 May; 212():107873. PubMed ID: 32165146 [TBL] [Abstract][Full Text] [Related]
17. Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoite. Edwinson A; Widmer G; McEvoy J Int J Parasitol; 2016 Jan; 46(1):67-74. PubMed ID: 26432292 [TBL] [Abstract][Full Text] [Related]
18. Effect of organic acids and hydrogen peroxide on Cryptosporidium parvum viability in fruit juices. Kniel KE; Sumner SS; Lindsay DS; Hackney CR; Pierson MD; Zajac AM; Golden DA; Fayer R J Food Prot; 2003 Sep; 66(9):1650-7. PubMed ID: 14503720 [TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum. Rochelle PA; Marshall MM; Mead JR; Johnson AM; Korich DG; Rosen JS; De Leon R Appl Environ Microbiol; 2002 Aug; 68(8):3809-17. PubMed ID: 12147476 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts. Ahmed SA; El-Mahallawy HS; Karanis P Parasitol Res; 2019 Jul; 118(7):2053-2063. PubMed ID: 31187224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]